GlycoMira Therapeutics is developing therapeutics for Mucosal Diseases. Current R&D focus on mitigating radiation-induced injuries (Oral Mucositis & Acute Radiation Syndrome) and chronic rhinosinusitis.
Company Details
- Employees
- 9
- Founded
- 2008
- Address
- 675 Arapeen Drive Ste 302, Salt Lake City,ut 84108,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.glycomira.com
- Keywords
- anti-inflammatory, mucositis, periodontitis, glycobiology, radiation biology, inflammation, cancer supportive care, palliative care, Chronic Rhinosunusitis.
- HQ
- Salt Lake City, UT
Glycomira Therapeutics, Inc. Questions
Glycomira Therapeutics, Inc.'s website is http://www.glycomira.com
Glycomira Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/glycomira-inc
Glycomira Therapeutics, Inc. has
9 employees.
View email and phone details for 9
employees at Glycomira Therapeutics, Inc..
Glycomira Therapeutics, Inc.'s industry is
Pharmaceutical Manufacturing
Glycomira Therapeutics, Inc.'s top competitors are
Echelon Biosciences,
Curza,
Recursion,
Synvax Pharmaceuticals, Inc.,
Cibus Biotechnologies,
Maly Consulting Llc,
Rb Health Manufacturing Llc,
Blackrock Neurotech,
Halia Therapeutics, Inc.,
Carterra.
Glycomira Therapeutics, Inc.'s categories are Pharmaceutical Manufacturing
Glycomira Therapeutics, Inc.'s founding year is 2008
